Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T64205 | Target Info | |||
| Target Name | Signal transducer and activator of transcription 1 (STAT1) | ||||
| Synonyms | Transcription factor ISGF-3 components p91/p84; Signal transducers and activators of transcription factor; Signal transducer and activator of transcription 1-alpha/beta; STAT-1; P91 | ||||
| Target Type | Patented-recorded Target | ||||
| Gene Name | STAT1 | ||||
| Biochemical Class | Transcription factor | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | |||||
| Patent ID | WO2006071812 | ||||
| Title | Platinum Iv Complex Inhibitor. | ||||
| Abstract | The invention disclosed herein provides methods for diagnosing and treating diseases and/or conditions associated with dysregulated Stat3-mediated activity. | ||||
| Applicant(s) | H. Lee Moffitt Cancer Center and Research Institute | ||||
| Representative Drug(s) | D01BVU | Drug Info | IC50 = 4100 nM | [1] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | A STAT inhibitor patent review: progress since 2011.Expert Opin Ther Pat. 2015;25(12):1397-421. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.